NCT04557787View on ClinicalTrials.gov

Investigation of Non-CE Marked Intermittent Catheters for Females

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Retention, Urinary
Interventions
DEVICE

SpeediCath® Standard female

Intermittent catheterization through the urethra draining the bladder, using SpeediCath® Standard female.

DEVICE

New intermittent Variant 1 catheter for females

Intermittent catheterization through the urethra draining the bladder, using the new Variant 1 catheter.

DEVICE

New intermittent Variant 2 catheter for females

Intermittent catheterization through the urethra draining the bladder, using the new Variant 2 catheter.

Trial Locations (1)

2100

Urologisk klinik, Afsnit 2112, Rigshospitalet, Copenhagen

Sponsors

Lead Sponsor

Coloplast A/S
All Listed Sponsors
lead

Coloplast A/S

INDUSTRY